BioSpace News Archive

Drug Development

Bone Therapeutics Extends ALLOB® Phase I/IIa Trial To Germany

October 9, 2014
·
5 min read
Drug Development

Boston Therapeutics, Inc. Reports Topline U.S.-Based Phase 2b Study Results Of BTI-320 In Patients With Type 2 Diabetes

October 9, 2014
·
6 min read
Pharm Country

B.Braun Medical To Distribute BSmart™ Injection Pressure Monitor For Peripheral Nerve Blocks Beginning Q1 2015

October 9, 2014
·
4 min read
Pharm Country

Quantum Installs A Q-Rad Digital System For MLB’s New York Mets At Citi Field

October 9, 2014
·
3 min read
Drug Development

Shionogi, Inc. Release: Novel Siderophore Cephalosporin S-649266 Pre-Clinical Results Suggest Potent Activity Against Multidrug-Resistant Gram-Negative Pathogens

October 9, 2014
·
6 min read
Policy

Synthon Pharmaceuticals Announces Filing Of Glatiramer Acetate 40 Mg/Ml ANDA Containing A Paragraph IV Certification

October 9, 2014
·
2 min read
BioMidwest

AtriCure, Inc. Completes Enrollment In Post Approval Study For The Synergy™ Ablation System

October 9, 2014
·
1 min read
Biotech Bay

University of California, Santa Cruz (UCSC) Leads $11 Million Center For Big Data In Translational Genomics

October 9, 2014
·
5 min read
Drug Development

Cyclacel Pharmaceuticals, Inc. Announces Data Safety Monitoring Board Recommendation To Continue The Seamless Phase 3 Trial Of Sapacitabine In AML

October 9, 2014
·
2 min read
Policy

FDA Needs More Pediatric Data For Resubmission Of ADHD Drug: Shire

October 9, 2014
·
1 min read